C), and Zinc , designed to enhance your bodys natural defenses and promote overall health
STEP UP directly compared 7.2 mg with 2.4 mg and placebo over 72 weeks: FDA prescribing information
BPC-157 is not approved for human or veterinary use by any regulatory agency
Research points to an underlying genetic vulnerability, with multiple potential contributing factors, including medications, environmental toxins, infections, vaccines, mitochondrial dysfunction, methylation defects, nutrient deficiencies, and the gut microbiome
Originally developed by Metabolic Pharmaceuticals in Australia during the 1990s, this synthetic peptide was designed to harness growth hormones fat-mobilizing properties while avoiding the metabolic complications associated with full-length GH therapy